Join us for an exciting, expert-led panel discussion on the emerging role of next generation circular RNA (circRNA) biomarkers in brain health and neurodegenerative disease. In this webinar, we will explore the biological significance of brain-derived circRNAs, their stability and how these properties enable blood-based detection for neurological conditions.
We will also share the latest clinical validation data demonstrating circRNA performance in identifying Alzheimer’s disease (AD) and predicting disease progression across cognitively impaired and unimpaired populations.
The session will conclude with a discussion on the future potential of circRNA biomarkers including the introduction of our upcoming Research Use Only (RUO) assay designed to support clinical research collaborations and biomarker-driven studies in Alzheimer’s disease and other neurodegenerative diseases.
Key Highlights
- Explore circular RNA (circRNA) biology, its role in brain health, and the mechanistic pathways linking circRNAs to neurodegeneration.
- Review the latest clinical validation data demonstrating circRNA performance in Alzheimer’s disease detection.
- Understand emerging use cases for circRNA biomarkers in clinical research and therapeutic development.
Why Attend?
- Learn about the role of circRNAs in modulating and regulating important biological disease pathways implicated in the development of neurodegenerative diseases
- Learn how circRNA biomarkers may enable earlier detection and improve patient stratification and risk profiling in Alzheimer’s disease
- Discover how circRNAs can support preclinical AD risk assessment and disease progression prediction
- Gain insights into the emerging role of circRNA biomarkers in advancing the field of blood-based biomarkers in Alzheimer’s disease.
Webinar Panelists
Nikolas Mellios, MD, PhD
Chief Scientific Officer
Henrik Zetterberg, MD, PhD
Professor of Neurochemistry at the University of Gothenburg, Sweden, University of Wisconsin-Madison, and University College London (UCL)
You May Also Be Interested In…
Learn More About Autoimmune
- The Most Comprehensive Way to Search the Autoimmune Drug Development Landscape: Unique search ontologies based on Autoimmune drug and trial characteristics
- Market Leading Approach to Autoimmune Preclinical & Clinical Data Curation: Manual curation of key Autoimmune research and development data points by Autoimmune research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Autoimmune company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
